MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone.

Zhao, Sai; Mao, Li; Wang, Shou-Guo; Chen, Feng-Li; Ji, Feng; Fei, Hao-Dong

Zhao, Sai; Mao, Li; Wang, Shou-Guo; Chen, Feng-Li; Ji, Feng; Fei, Hao-Dong.

Afiliación

Zhao S; Department of Pediatrics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Mao L; Department of Endocrinology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Wang SG; Department of Orthopedics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Chen FL; Clinical Laboratory, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Ji F; Department of Orthopedics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Fei HD; Department of Orthopedics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.

Oncotarget ; 8(62): 104867-104876, 2017 Dec 01.

Article en En | MEDLINE | ID: mdl-29285219

Palabras clave

Nrf2; dexamethasone; keap1; miR-200a; osteoblasts

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google